Philadelphia – JAMS, the largest private provider of alternative dispute resolution (ADR) services worldwide, is pleased to announce that Hon. Gregory M. Sleet (Ret.) has been appointed by U.S. District Judge Robert B. Kugler to serve as a special master in multidistrict litigation (MDL) involving the blood pressure drug Valsartan.
Judge Sleet, alongside Hon. Lawrence F. Stengel (Ret.), will preside over settlement negotiations relating to the MDL, which alleges that manufacturers, wholesalers and pharmacies failed to prevent contamination of Valsartan. In 2018, an investigation by the United States Food and Drug Administration found impurities in the drug, prompting several voluntary recalls and the filing of class action suits by consumers alleging personal injuries and financial losses.
With 20 years of experience serving on the bench of the United States District Court for the District of Delaware, including seven years as chief judge, Judge Sleet has deep experience in various areas of complex commercial litigation. As a JAMS neutral in Philadelphia, he focuses his practice on mediations, arbitrations and neutral analysis, including case evaluation and mock trials.
About JAMS – Local Solutions. Global Reach.
Founded in 1979, JAMS is the largest private provider of alternative dispute resolution services worldwide. JAMS successfully resolves and manages business and legal disputes by providing efficient, cost-effective and impartial ways to overcome barriers at any stage of conflict. JAMS offers customized dispute resolution services locally and globally through a combination of industry-specific experience, first-class client service, top-notch facilities and highly trained panelists.
With a roster of over 400 neutrals and 29 locations, JAMS resolves thousands of the world’s important cases every year. JAMS also offers remote dispute resolution through videoconferencing and other platforms. JAMS neutrals are adept at managing the resolution process whether they are conducting in-person or virtual hearings.